<![CDATA[NCKU News Center - NEWS]]> utf-8 2024-04-12 09:37:20 2024-04-12 09:37:20 <![CDATA[Vietnamese Culture Week 2024 program from April 13 to 20, 2024]]> 2024-04-12 <![CDATA[Leveraging on Interdisciplinary Collaboration, NCKU held International Forum and Workshop on Happiness Education to Advocate Mental Health]]> 2024-04-11 <![CDATA[Delegation Led by Eswatini PM Dlamini Visits NCKU for Exchange on Disaster Prevention Education and Disaster Management System]]> 2024-04-10 <![CDATA[RedBall Project at NCKU Future Venue: Uniting Art and Heritage]]> 2024-04-09 <![CDATA[I-Ching Chen, Associate Professor at National Cheng Kung University, published a study in Nature revealing global mountain climate velocities, highlighting 17 high-risk regions]]> 2024-03-28 <![CDATA[Taiwan-Thailand Scientific Research and Technology Innovation Center Unveiled in Bangkok to Deepen and Broaden Bilateral Cooperation in Science and Technology]]> 2024-03-20 <![CDATA[NCKU Achieves Four First Places in 2024 University Brand Rankings, Recognized by Enterprises for Teamwork, Communication, and Adaptability]]> 2024-03-12 <![CDATA[President Shen Attends the 10th Anniversary Gathering of the Indonesian Alumni Association]]> 2024-03-05 <![CDATA[Focusing on Sustainable and Diverse Proposals, NCKU Holds Campus Finals for the Hult Prize]]> 2024-02-27 <![CDATA[NCKU Research Team, Led by Prof. Win-Pin Su, Achieves Breakthrough in Lung Cancer Treatment: Published Study on Tumor Microenvironment Remodeling Using Nanotechnology in Prestigious Journal《 Nano Today 》]]> Tumor microenvironment (TME) primarily contributes to resistance in clinical antineoplastic treatment. In non-small-cell lung cancers (NSCLCs), the frequently mutated KRAS oncogene (mainly at the KRASG12C position) promotes tumor progression. The interdisciplinary research team at NCKU has successfully nano-formulated the small-molecular drug Sitravatinib (currently undergoing clinical trials internationally) using polymeric nanoparticles to form the novel nano-drug Au@PSMA-Sit. In the murine lung cancer model bearing KRASG12C mutant TME, Au@PSMA-Sit nanoparticles exhibit outstanding antitumor efficacy, requiring a lower therapeutic dosage (1/10) of sitravatinib. These experimental achievements were published in the authoritative international journal Nano Today in February 2024 with an impact factor of 17.4. Polymeric nano-formulation of spectrum selective RTK inhibitor strengthens anti-cancer effects via immune remodeling by endoplasmic reticulum stress-modulating mitochondrial metabolism]]> 2024-02-26 <![CDATA[Dr. Nguyen Thi Nghi Nhan Receives Prestigious "Best PhD Thesis Award" at the International Solvothermal and Hydrothermal Association Conference, Valladolid, Spain]]> 2024-02-17 <![CDATA[NCKU Takes the Crown Once More in the 2024 Enterprises’ Favorite Survey]]> 2024-02-06 <![CDATA[CECI Signs Memorandum of Understanding for Enhanced Collaboration with National Cheng Kung University]]> 2024-01-29 <![CDATA[NCKU and Delta Electronics Unveil Joint Research Center, Focusing on Green Energy and Smart Automation Applications]]> 2024-01-26 <![CDATA[Selfies of NCKU Lilium-1 From Low Earth Orbit]]> 2024-01-26 <![CDATA[ASE-NCKU Inaugurate Joint R&D Center to Drive Innovation and Talent Cultivation]]> 2024-01-25 <![CDATA[NCKU Confers Honorary Doctorate to Bowei Lee, Chairman of the LCY Group]]> 2024-01-16 <![CDATA[As Smart Healthcare Gains Momentum, NCKU Hospital Hosts “Road to Smart Healthcare Seminar” on December 9th,2023.]]> 2024-01-12 <![CDATA[Quanta-NCKU Joint AI Research Center opened on December 15]]> 2023-12-28 <![CDATA[President Shen Attends the 55th Annual Meeting of the Alumni Association of Southern California]]> 2023-12-22